Emerging role for pharmacogenomics in HIV research in Africa

Pharmacogenomics is the study of genes that affect response to drugs. It combines pharmacological and genomics principles, to predict effectiveness and safety of therapeutic agents. This is, in part, because drug response and toxicity are influenced by pharmacokinetic factors that result in interin...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhou, Danai Tavonga, Mudhluli, Taona Emmah, Madhombiro, Munyaradzi, Nyamhunga, Albert, Matekaire-Chirimo, Ratidzo, Mudzviti, Tinashe, Manasa, Justen, Ma, Qing, Maponga, Charles Chiedza, Morse, Gene D
Format: Article
Language:English
Published: Future Science Group 2022
Subjects:
Online Access:https://www.futuremedicine.com/doi/pdf/10.2217/fvl-2020-0388
http://hdl.handle.net/11408/4756
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1779905227612225536
author Zhou, Danai Tavonga
Mudhluli, Taona Emmah
Madhombiro, Munyaradzi
Nyamhunga, Albert
Matekaire-Chirimo, Ratidzo
Mudzviti, Tinashe
Manasa, Justen
Ma, Qing
Maponga, Charles Chiedza
Morse, Gene D
author_facet Zhou, Danai Tavonga
Mudhluli, Taona Emmah
Madhombiro, Munyaradzi
Nyamhunga, Albert
Matekaire-Chirimo, Ratidzo
Mudzviti, Tinashe
Manasa, Justen
Ma, Qing
Maponga, Charles Chiedza
Morse, Gene D
author_sort Zhou, Danai Tavonga
collection DSpace
description Pharmacogenomics is the study of genes that affect response to drugs. It combines pharmacological and genomics principles, to predict effectiveness and safety of therapeutic agents. This is, in part, because drug response and toxicity are influenced by pharmacokinetic factors that result in interindividual variability in drug-metabolizing enzymes and membrane transporters [1]. Variants of relevance include members of the cytochrome P450 (CYP450) family. Genetic variation of CYP450 genes alone is estimated to influence a quarter of all drug therapies [2]. Pharmacogenomic research is thus imperative for development and function of drugs, including antiretrovirals, anticancer medicines, antibiotics and lipid-lowering therapies, among others. Pharmacogenomics research in Africa is especially valuable in the context of high genetic variability [1,3], high HIV burden and growing noncommunicable disease incidence. A recent publication on whole genome sequencing in hundreds of people from across Africa revealed an unexpectedly large number of new single-nucleotide variants [4]. Yet, less than a quarter of participants in current genomics (and by extension pharmacogenomics) research are non-Europeans, leaving out a large majority of human genetic variants [5]. The need for more inclusive genetic research further attests to the emerging role for pharmacogenomic studies across Africa.
format Article
id ir-11408-4756
institution My University
language English
publishDate 2022
publisher Future Science Group
record_format dspace
spelling ir-11408-47562022-06-27T13:49:06Z Emerging role for pharmacogenomics in HIV research in Africa Zhou, Danai Tavonga Mudhluli, Taona Emmah Madhombiro, Munyaradzi Nyamhunga, Albert Matekaire-Chirimo, Ratidzo Mudzviti, Tinashe Manasa, Justen Ma, Qing Maponga, Charles Chiedza Morse, Gene D Africa HIV medicines pharmacogenetics pharmacogenomics research treatment Pharmacogenomics is the study of genes that affect response to drugs. It combines pharmacological and genomics principles, to predict effectiveness and safety of therapeutic agents. This is, in part, because drug response and toxicity are influenced by pharmacokinetic factors that result in interindividual variability in drug-metabolizing enzymes and membrane transporters [1]. Variants of relevance include members of the cytochrome P450 (CYP450) family. Genetic variation of CYP450 genes alone is estimated to influence a quarter of all drug therapies [2]. Pharmacogenomic research is thus imperative for development and function of drugs, including antiretrovirals, anticancer medicines, antibiotics and lipid-lowering therapies, among others. Pharmacogenomics research in Africa is especially valuable in the context of high genetic variability [1,3], high HIV burden and growing noncommunicable disease incidence. A recent publication on whole genome sequencing in hundreds of people from across Africa revealed an unexpectedly large number of new single-nucleotide variants [4]. Yet, less than a quarter of participants in current genomics (and by extension pharmacogenomics) research are non-Europeans, leaving out a large majority of human genetic variants [5]. The need for more inclusive genetic research further attests to the emerging role for pharmacogenomic studies across Africa. 2022-03-24T14:04:37Z 2022-03-24T14:04:37Z 2021 Article 1746-0808 https://www.futuremedicine.com/doi/pdf/10.2217/fvl-2020-0388 http://hdl.handle.net/11408/4756 en Future Virology;Vol.15 , Iss.6 open Future Science Group
spellingShingle Africa
HIV
medicines
pharmacogenetics
pharmacogenomics
research
treatment
Zhou, Danai Tavonga
Mudhluli, Taona Emmah
Madhombiro, Munyaradzi
Nyamhunga, Albert
Matekaire-Chirimo, Ratidzo
Mudzviti, Tinashe
Manasa, Justen
Ma, Qing
Maponga, Charles Chiedza
Morse, Gene D
Emerging role for pharmacogenomics in HIV research in Africa
title Emerging role for pharmacogenomics in HIV research in Africa
title_full Emerging role for pharmacogenomics in HIV research in Africa
title_fullStr Emerging role for pharmacogenomics in HIV research in Africa
title_full_unstemmed Emerging role for pharmacogenomics in HIV research in Africa
title_short Emerging role for pharmacogenomics in HIV research in Africa
title_sort emerging role for pharmacogenomics in hiv research in africa
topic Africa
HIV
medicines
pharmacogenetics
pharmacogenomics
research
treatment
url https://www.futuremedicine.com/doi/pdf/10.2217/fvl-2020-0388
http://hdl.handle.net/11408/4756
work_keys_str_mv AT zhoudanaitavonga emergingroleforpharmacogenomicsinhivresearchinafrica
AT mudhlulitaonaemmah emergingroleforpharmacogenomicsinhivresearchinafrica
AT madhombiromunyaradzi emergingroleforpharmacogenomicsinhivresearchinafrica
AT nyamhungaalbert emergingroleforpharmacogenomicsinhivresearchinafrica
AT matekairechirimoratidzo emergingroleforpharmacogenomicsinhivresearchinafrica
AT mudzvititinashe emergingroleforpharmacogenomicsinhivresearchinafrica
AT manasajusten emergingroleforpharmacogenomicsinhivresearchinafrica
AT maqing emergingroleforpharmacogenomicsinhivresearchinafrica
AT mapongacharleschiedza emergingroleforpharmacogenomicsinhivresearchinafrica
AT morsegened emergingroleforpharmacogenomicsinhivresearchinafrica